Bionik Laboratories (Bionik Laboratories) Total Inventories : $1.03 Mil (As of Mar. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Bionik Laboratories Total Inventories?

Bionik Laboratories's total inventories for the quarter that ended in Mar. 2023 was $1.03 Mil. Bionik Laboratories's average total inventories from the quarter that ended in Dec. 2022 to the quarter that ended in Mar. 2023 was $1.09 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Bionik Laboratories's Net-Net Working Capital per share for the quarter that ended in Mar. 2023 was $-0.54.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Bionik Laboratories's Days Inventory for the three months ended in Mar. 2023 was 402.31.

Inventory Turnover measures how fast the company turns over its inventory within a year. Bionik Laboratories's Inventory Turnover for the quarter that ended in Mar. 2023 was 0.23.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bionik Laboratories's Inventory-to-Revenue for the quarter that ended in Mar. 2023 was 2.17.

Bionik Laboratories Total Inventories Historical Data

The historical data trend for Bionik Laboratories's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionik Laboratories Total Inventories Chart

Bionik Laboratories Annual Data

Trend

Dec14

Dec15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Inventories

Get a 7-Day Free Trial

0.41

1.06

0.69

1.19

1.03

Bionik Laboratories Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Inventories	Get a 7-Day Free Trial															1.19	1.42	1.35	1.14	1.03

Bionik Laboratories Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Bionik Laboratories (OTCPK:BNKL) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Bionik Laboratories's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2023 is

	Net-Net Working Capital Per Share (Q: Mar. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.427	+	0.75 * 0.453	+	0.5 * 1.034	-	5.003
-	0	-	0)	/	6.87816
=	-0.54

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bionik Laboratories's Days Inventory for the three months ended in Mar. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2023 )	/	Cost of Goods Sold (Q: Mar. 2023 )	*	Days in Period
	=	1.089	/	0.247	*	365 / 4
	=	402.31

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Bionik Laboratories's Inventory Turnover for the quarter that ended in Mar. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2023 )	/	Average Total Inventories (Q: Mar. 2023 )
	=	0.247	/	1.089
	=	0.23

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bionik Laboratories's Inventory to Revenue for the quarter that ended in Mar. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	1.089	/	0.501
	=	2.17

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Bionik Laboratories Total Inventories Related Terms

Thank you for viewing the detailed overview of Bionik Laboratories's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionik Laboratories (Bionik Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bionik Laboratories Corp (OTCPK:BNKL) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

80 Coolidge Hill Road, Watertown, MA, USA, 02472

Website

https://www.bioniklabs.com

Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.

Executives

Remi Gaston-dreyfus	director, 10 percent owner	46 RUE PIERRE CHARRON, PARIS I0 75008
Charles Matine	director	7 RUE GUSTAVE, FLAUBERT, PARIS I0 75017
Andre-jacques Auberton-herve	director, officer: Chairman	18 CHEMIN DE LA VIERGE NOIRE, LA TRONCHE I0 38700
Daniel Gonsalves	officer: Executive Vice President & CFO	80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Loren W. Wass	officer: See Remarks	34 HOG HILL ROAD, PEPPERELL MA 01463
Joseph R Martin	director
Audrey Thevenon	director	4500 WESTBROOK LANE, KENSINGTON MD 20895
Peter Gerald Malone	director
Russo Richard Paul Jr	officer: Chief Financial Officer	20 PLUNKETT WAY, TEWKSBURY MA 01876
Renaud Bertrand Maloberti	officer: Chief Commercial Officer	10 ACORN WAY, GEORGETOWN MA 01833
Timothy A. Mccarthy	officer: Chief Commercialization Office	C/O BIONIK, 483 BAY STREET, N105, TORONTO A6 M5G 2C9
Eric Michel Dusseux	director	1 RUE DU CAPOT, CALUIRE-ET-CUIRE I0 69300
Jules Marc Fried	officer: VP - U.S. Operations	C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Hermano Igo Krebs	officer: Chief Science Officer	C/O INTERACTIVE MOTION TECHNOLOGIES INC., 80 COOLIDGE HILL ROAD, WATERTOWN MA 02472
Marc Mathieu	director	716 BROOKS AVENUE, VENICE CA 90291